Detalhe da pesquisa
1.
Empagliflozin after Acute Myocardial Infarction.
N Engl J Med
; 390(16): 1455-1466, 2024 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38587237
2.
Ferric Carboxymaltose in Heart Failure with Iron Deficiency.
N Engl J Med
; 389(11): 975-986, 2023 Sep 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37632463
3.
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.
Circulation
; 149(21): 1627-1638, 2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38581389
4.
Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Circulation
; 147(23): 1748-1757, 2023 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37042255
5.
Improving Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction: A Review of Implementation Strategies.
J Card Fail
; 30(2): 376-390, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38142886
6.
Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions.
Curr Cardiol Rep
; 26(3): 61-71, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38551786
7.
Putting More Weight on Obesity Trials in Heart Failure.
Curr Heart Fail Rep
; 21(3): 194-202, 2024 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38619690
8.
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
Eur Heart J
; 44(20): 1807-1814, 2023 05 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37038327
9.
Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial.
Am Heart J
; 266: 25-31, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37598795
10.
Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure.
J Card Fail
; 29(6): 896-906, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36632934
11.
Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials.
J Card Fail
; 29(12): 1603-1614, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37479054
12.
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
Am Heart J
; 253: 86-98, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35595091
13.
Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction.
J Card Fail
; 28(12): 1652-1660, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35688408
14.
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events.
Heart Fail Clin
; 18(4): 597-607, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36216489
15.
Prioritizing Quad Therapy and the Path Forward in Guideline-Directed Medical Therapy for Patients With Heart Failure With Reduced Ejection Fraction.
Circulation
; 145(15): 1105-1107, 2022 04 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35404676
16.
Catastrophic Disruptions in Clinical Trials.
Circulation
; 146(5): 369-371, 2022 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35914015
17.
Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach.
Curr Diab Rep
; 18(9): 64, 2018 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30008022
18.
Bleeding and risk for future cardiovascular events in patients with atrial fibrillation on oral anticoagulation: major bleeding is a major problem.
Eur Heart J
; 43(47): 4909-4911, 2022 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36380455
19.
Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure.
Eur Heart J
; 43(41): 4433-4435, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36036745
20.
Leveraging Multiple Biomarkers to Assess Risk of Acute Heart Failure: Is More Better?
J Card Fail
; 28(2): 234-236, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34952784